A recent study highlighted SPP1 as a central mediator of monocyte-to-endothelial signaling in thrombosis (70), and elevated osteopontin is a strong predictor of poor outcome in stroke, myocardial infarction (71) and DVT (72). This evidence concerns the gene SPP1 and myocardial infarction.